Abstract
On November 14, 2019, the U.S. Food and Drug Administration (FDA) approved cefiderocol, a sidero-phore-cephalosporin conjugate antibiotic, for the tre......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
